Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer

Diseases of the Colon and Rectum

Volumn 40, Issue 12, 1997, Pages 1414-1420

  Pokorny, Richard M ^a   Wrightson, William R ^a   Lewis, Robert K ^a   Paris, Kristie J ^a   Hofmeister, Annegret ^a   LaRocca, Renato ^a   Myers, Steven R ^a   Ackerman, Douglas ^a   Galandiuk, Susan ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

5 Fluorouracil; Chemotherapy; Mitomycin C; Radiation; Rectal neoplasms; Suppositories

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN C;

ALOPECIA; ANEMIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIARRHEA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECTAL DRUG ADMINISTRATION; RECTUM CANCER; SUPPOSITORY; TREATMENT OUTCOME;

EID: 0030708678     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02070704     Document Type: Article

References (15)

1. Shumate CR, Rich TA, Skibber JM, Ajani JA, Ota DM. Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma: a report of surgical morbidity. Cancer 1993;71: 3690-6.
2. Shukla HS, Hughes LE, Davis PW, Whitehead RH, Leach KG. Distribution of 5-fluorouracil to body tissues compared after intraluminal, intravenous, and intramural administration in gastrointestinal cancer. Am J Surg 1977;133:346-50.
3. Cummings J, Spanswick VJ, Smyth JF. Reevaluation of the molecular pharmacology of mitomycin C. Eur J Cancer 1995;31A:1928-33.
4. Steel GG. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988;11:31-53.
5. Picciocchi A, Coco C, Magistrelli P, et al. Concomitant preoperative radiochemotherapy in operable locally advanced rectal cancer. Dis Colon Rectum 1994; 37(Suppl):S69-72.
6. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7.
7. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991;324:709-15.
8. Takahashi T, Kohno K, Yamaguchi T, Narisawa T. Preoperative use of 5-fluorouracil suppository for carcinoma of the rectum. Am J Surg 1982;143:183-5.
9. Takahashi T, Mizusawa H, Kato T, Yamaguchi T. Preoperative irradiation and 5-fluorouracil suppository for carcinoma of the rectum. Am J Surg 1988;156:58-62.
10. Galandiuk S, Wrightson WR, Marr L, Myers SR, LaRocca RD. Suppository delivery of 5-fluorouracil in rectal cancer. Ann Surg Oncol 1996;3:270-6.
11. Tjaden UR, Langenberg JP, Ensing K, Vanbennekom WP. Determination of mitomycin C in plasma, serum and urine by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr 1982;232:355-67.
12. Fuchs CS, Mayer RJ. Adjuvant chemotherapy for colon and rectal cancer. Semin Oncol 1995;22:472-87.
13. Schmoll HJ. Colorectal carcinoma: current problems and future perspectives. Ann Oncol 1994;5S:115-21.
14. Papillon J. Surgical adjuvant therapy for rectal cancer: present options. Dis Colon Rectum 1994;37:144-8.
15. Meade PG, Blatchford GJ, Thorson AG, Christensen MA, Ternent CA. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am J Surg 1995;170:609-12.